Universal Biosensors (ASX:UBI) appointed David Hardy, James Dampney, and Emily Seeckts of KPMG as joint and several voluntary administrators of the company and its units, according to a Wednesday filing with the Australian bourse.
The administrators will start to access the recapitalization and sale process for the group, the filing said.
The first statutory meeting of the company's creditors is expected on Aug. 29, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.